Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
The Effect of Rectal Progesterone on the Latency period as well as Maternal and Prenatal Outcome in PPROM Between 24-33+6 Weeks	Umm Al Qura University	Ongoing	Progesterone	3	ISRCTN65694106	Umm Al Qura University, King Abdulaziz University Hospital (Jeddah), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah)
Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes	King Abdulaziz University Hospital	Completed	Black Cumin Oil	2	95-15	King Abdulaziz University Hospital (Jeddah)
Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients	King Fahad Specialist Hospital - Dammam	Ongoing	Gum Arabic / E-114	2	2	King Fahad Specialist Hospital (Dammam)
Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial.	KAIMRC	Ongoing	PEGINTERFERON ALFA-2A/ RIBAVIRIN/ R0209963	3	RC14-055-R	King Abdulaziz Medical City NG (Riyadh)
Efficacy and Safety of Intensive Insulin Therapy With Insulin Glulisine in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs	Sanofi	Ongoing	Lantus® / Apidra®	4	LANTU_R_05048	National Diabetes Centre (Riyadh)
An observational study to monitor 2- Combination regimen's patterns of oral hypoglycaemic agents in Type 2 diabetic patients in daily clinical practice in Saudi Arabia	Sanofi	Ongoing	2-combination hypoglycaemics	4	DIREG_L_05386	Dr. Erfan & Bagedo General Hospital (Jeddah)
Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after DOCETAXEL-based regimen	Sanofi	Ongoing	N/A	4	DRIEG_C_05756	King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
An observational Study to evaluate the behaviour of physicians focusing on the preference patterns (reasons to prescribe) of ARB/HCTZ combinations containing high dose (25mg) diuretic for treatment of hypertension in Saudi Arabia	Sanofi	Ongoing	N/A	4	IRBEH_L_05674	King Khalid University Hospital (Riyadh)
Effect of ACS Patients' Education on Adherence to Dual Anti-platelet Therapy (unstable angina + non ST elevation MI + ST elevation MI)	Sanofi	Ongoing	N/A	4	DIREG_L_05229	Dr. Soliman Fakeeh Hospital (Jeddah)
Phase IV, Multicenter, International, Non-comparative, Open Label Study of Efficacy and Safety of Basal Bolus Therapy (Insulin Glargine + Insulin Glulisine) in Patients With T1 Diabetes Previously Uncontrolled on Any Insulin Regimen.	Sanofi	Ongoing	Lantus® + Apidra®	4	LANTU_R_05033	King Khalid University Hospital (Riyadh)